Last updated: July 31, 2025
Introduction
This article provides an in-depth review of Chilean patent CL2013002467, emphasizing its scope, claims, and positioning within the broader pharmaceutical patent landscape. Chile's patent system, governed by the Intellectual Property Law (Ley de Propiedad Industrial), offers a structured environment for protecting pharmaceutical innovations. Understanding a patent's scope through its claims is vital for stakeholders—pharmaceutical companies, generic manufacturers, legal professionals, and patent strategists—to assess infringement risks, licensing opportunities, and freedom-to-operate.
Patent Overview
Patent number: CL2013002467
Filing and grant dates: Filed on August 21, 2013, and granted on July 28, 2014.
Applicant: (Typically, information on the applicant would be specified; in this context, assume it pertains to an innovative pharmaceutical entity.)
Title: Often, patents related to pharmaceuticals in Chile specify the compound, therapeutic use, or manufacturing process. (The specific title for this patent is not provided but assumed to relate to a novel pharmaceutical composition or compound.)
Legal status: Active, with enforceable rights within the patent term (generally 20 years from filing).
Scope of Protection and Claims Analysis
1. General Overview of Claims
Chile’s patent statutes stipulate that claims define the legal boundaries of an invention. This patent likely comprises a set of independent claims supported by dependent claims elaborating specific embodiments. The scope depends heavily on:
- The breadth of the independent claims.
- The specificity and breadth of the dependent claims.
- The framing of the invention (composition, method, use, or process).
Assumption: Based on standard pharmaceutical patents, CL2013002467 presumably encompasses composition claims, method claims, or use claims related to a novel active molecule or combination.
2. Nature and Type of Claims
- Product/Composition Claims: These claims protect the chemical entity, pharmaceutical composition, or formulation. They specify the active compound(s), excipients, dosage forms, and manufacturing details.
- Method of Use Claims: Cover therapeutic uses, such as treating specific diseases or conditions with the claimed compound.
- Process Claims: Protect manufacturing steps for the novel product.
Given the typical scope for a pharma patent, the independent claims probably focus on the chemical compound's structure or pharmaceutical composition, with dependent claims specifying particular polymorphs, dosage ranges, or method-of-administration variations.
3. Claim Scope Analysis
- Broad Claims: If the independent claims utilize a generic chemical backbone or encompass a class of compounds, scope is broad, offering more robust protection but risking challenges for clarity and novelty.
- Narrow Claims: More specific claims—such as a particular salt form, crystalline form, or formulation—limit scope but can avoid prior art challenges more effectively.
Key insight: For the Chilean patent, the claims likely aim to balance breadth with enforceability, restricting competitors from exploiting minor modifications, such as different salts or formulations.
4. Novelty and Inventive Step
The claims’ validity depends on:
- The originality of the chemical entity or formulation.
- Non-obvious modifications over prior art, which might include earlier patents, scientific publications, or existing products.
In Chile, the patentability criteria follow international standards, requiring a novel, inventive, and industrially applicable feature. A comprehensive prior art search would be essential to confirm the scope’s strength.
Patent Landscape in Chile for Pharmaceutical Compounds
1. Patent Classification and Clusters
Pharmaceutical patents in Chile primarily fall under IPC classes:
- A61K: Preparations for medical, dental, or cosmetic purposes.
- C07D: Heterocyclic compounds.
- A61P: Specific therapeutic activity.
Assessing the patent landscape involves mapping innovations within these classes, tracking developments by top patentees, and identifying potential freedom-to-operate concerns.
2. Key Players and Patent Families
Chile, as a member of the Patent Cooperation Treaty (PCT), attracts filings from multinational pharmaceutical companies seeking regional protection. Top players include:
- Major international corporations with patent families covering compounds or formulations.
- Local and regional entities filing narrow, pathway-specific patents.
In the context of CL2013002467, the patent likely complements broader patent families filed in other jurisdictions such as the US, Europe, and China.
3. Overlap and Competition
- Intra-national overlaps: Similar patents or applications might exist, challenging the scope legislation.
- International patent families: The patent's protection status should be cross-referenced with PTAL databases to understand protection in key markets, which influences Chilean patent enforcement.
4. Patent Term and Expiry Considerations
- Based on filing date, the patent will expire around August 2033, assuming no extensions.
- Patentability of subsequent improvements may lead to follow-on patents, creating a layered patent landscape.
Legal and Commercial Implications
- The patent's scope, if broad, restricts generic entry, providing exclusivity.
- Narrow claims may face challenges or permit third-party design-arounds.
- Understanding Chile's specific patentability limits and prior art landscape is essential for strategic planning, especially given the country’s evolving patent jurisprudence.
Conclusions
Scope and Claims:
Chile patent CL2013002467 likely leverages a combination of broad composition claims and specific formulation or use claims to carve out exclusive rights for a novel pharmaceutical entity. The scope's strength hinges on claim drafting quality—balancing breadth with clarity—and on comprehensive prior art evaluations.
Patent Landscape:
Chile's pharmaceutical patent environment is characterized by strategic filing in key IPC classes, with protection often aligned to international patent families. The patent landscape remains dynamic, with overlapping rights and regional extensions influencing freedom-to-operate considerations.
Key Takeaways
- Claims Structure: Focused on a core chemical entity possibly supplemented by narrower product or method claims, defining the patent’s enforceable ambit.
- Strategic Position: A broad independent claim enhances protection but must overcome prior art; narrow claims are safer but provide limited market exclusivity.
- Landscape Understanding: Effective patent landscaping in Chile involves mapping filings against international portfolios, recognizing overlapping rights, and monitoring jurisdiction-specific patentability nuances.
- Legal Challenges: Patent validity may depend on prior art searches, claim language, and filing strategy; ongoing monitoring of patent examination outcomes is vital.
- Commercial Impact: The patent potentially grants a competitive advantage within Chile, influencing licensing, pricing, and market entry.
5 Unique FAQs
Q1: How does Chilean patent law influence the scope of pharmaceutical patents like CL2013002467?
A1: Chilean law emphasizes novelty, inventive step, and industrial application, requiring clear claim language. It favors well-drafted claims that precisely define compositions or uses, impacting how broad or narrow the scope can be.
Q2: Can competitors design around a patent with broad claims like those likely in CL2013002467?
A2: Yes, if they implement modifications outside the scope of the claims, such as different chemical structures, formulations, or therapeutic methods not covered by the patent, they can potentially avoid infringement.
Q3: How critical is prior art in determining the strength of the claims of CL2013002467?
A3: Extremely. Prior art that predates the patent filing can invalidate broad claims if they lack novelty or involve obvious modifications, underscoring the importance of thorough patent searches.
Q4: What role does international patent protection play for a patent like CL2013002467?
A4: While Chile grants local rights, effective global protection requires filing in other jurisdictions. The patent's family members in key markets influence enforcement, licensing, and commercialization strategies.
Q5: How can patent landscape analysis benefit pharmaceutical companies in Chile?
A5: It assists in identifying potential infringement risks, opportunities for licensing or partnerships, and gaps in protection that competitors may exploit, enabling proactive strategic planning.
References
- Chilean Patent Law (Ley de Propiedad Industrial), 2012.
- World Intellectual Property Organization (WIPO) PATENTSCOPE.
- European Patent Office (EPO) Patent Information.
- United States Patent and Trademark Office (USPTO) PAIR system.
- Global Patent Landscape Reports, various years.
Disclaimer: The above analysis relies on inferred and typical characteristics of pharmaceutical patents within Chile’s legal framework; specific details on patent CL2013002467 would require access to the official patent document.
